Edwin Jao Phones & Addresses
-
7721 Water St, Fulton, MD 20759 (908) 391-6916
-
15170 Sapling Ridge Dr, Dayton, MD 21036
-
Clarksville, MD
-
20 Crosswood Way, Warren, NJ 07059
-
Kenilworth, NJ
-
Iselin, NJ
-
7721 Water St, Fulton, MD 20759
Work
Position:
Professional/Technical
Education
Degree:
Associate degree or higher
Publications
Us Patents
Peptides As Ns3-Serine Protease Inhibitors Of Hepatitis C Virus
View pageUS Patent:
6800434, Oct 5, 2004
Filed:
Jul 19, 2001
Appl. No.:
09/909062
Inventors:
Anil K. Saksena - Upper Montclair NJ
Viyyoor Moopil Girijavallabhan - Parsippany NJ
Raymond G. Lovey - West Caldwell NJ
Edwin Jao - Warren NJ
Frank Bennett - Piscataway NJ
Jinping L. McCormick - Edison NJ
Haiyan Wang - Cranbury NJ
Russell E. Pike - Stanhope NJ
Stephane L. Bogen - Somerset NJ
Yi-Tsung Liu - Morris Township NJ
Ashok Arasappan - Bridgewater NJ
Tejal Parekh - Mountain View CA
Patrick A. Pinto - Morris Plains NJ
F. George Njoroge - Warren NJ
Ashit K. Ganguly - Upper Montclair NJ
Terence K. Brunck - Santa Fe NM
Scott Jeffrey Kemp - San Diego CA
Odile Esther Levy - San Diego CA
Marguerita Lim-Wilby - La Jolla CA
Viyyoor Moopil Girijavallabhan - Parsippany NJ
Raymond G. Lovey - West Caldwell NJ
Edwin Jao - Warren NJ
Frank Bennett - Piscataway NJ
Jinping L. McCormick - Edison NJ
Haiyan Wang - Cranbury NJ
Russell E. Pike - Stanhope NJ
Stephane L. Bogen - Somerset NJ
Yi-Tsung Liu - Morris Township NJ
Ashok Arasappan - Bridgewater NJ
Tejal Parekh - Mountain View CA
Patrick A. Pinto - Morris Plains NJ
F. George Njoroge - Warren NJ
Ashit K. Ganguly - Upper Montclair NJ
Terence K. Brunck - Santa Fe NM
Scott Jeffrey Kemp - San Diego CA
Odile Esther Levy - San Diego CA
Marguerita Lim-Wilby - La Jolla CA
Assignee:
Schering Corporation - Kenilworth NJ
Dendreon Corporation - Seattle WA
Dendreon Corporation - Seattle WA
International Classification:
A61K 3800
US Classification:
435 5, 435 6, 435 23, 514 9, 514 17, 514 18, 514160, 424 854, 530324, 530325, 530326, 530327, 530328, 530329
Abstract:
The present invention discloses novel peptide compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such peptides as well as methods of using them to treat disorders associated with the HCV protease.
Macrocyclic Ns3-Serine Protease Inhibitors Of Hepatitis C Virus Comprising N-Cyclic P2 Moieties
View pageUS Patent:
6846802, Jan 25, 2005
Filed:
Apr 3, 2001
Appl. No.:
09/825399
Inventors:
Kevin X. Chen - Piscataway NJ, US
Ashok Arasappan - Bridgewater NJ, US
Srikanth Venkatraman - Fords NJ, US
Tejal Parekh - Woodbridge NJ, US
Haining Gu - Minhang, CN
George F. Njoroge - Union NJ, US
Viyyoor Moopil Girijavallabhan - Parsippany NJ, US
Ashit Ganguly - Upper Montclair NJ, US
Anil Saksena - Upper Montclair NJ, US
Edwin Jao - Warren NJ, US
Nanhua Hugh Yao - Edison NJ, US
Andrew Joseph Prongay - Stewartsville NJ, US
Vincent Stewart Madison - Mountain Lakes NJ, US
Bancha Vibulbhan - Kenilworth NJ, US
Ashok Arasappan - Bridgewater NJ, US
Srikanth Venkatraman - Fords NJ, US
Tejal Parekh - Woodbridge NJ, US
Haining Gu - Minhang, CN
George F. Njoroge - Union NJ, US
Viyyoor Moopil Girijavallabhan - Parsippany NJ, US
Ashit Ganguly - Upper Montclair NJ, US
Anil Saksena - Upper Montclair NJ, US
Edwin Jao - Warren NJ, US
Nanhua Hugh Yao - Edison NJ, US
Andrew Joseph Prongay - Stewartsville NJ, US
Vincent Stewart Madison - Mountain Lakes NJ, US
Bancha Vibulbhan - Kenilworth NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A16K 3812
US Classification:
514 9, 514411, 540469, 530317
Abstract:
The present invention discloses novel macrocyclic compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such macrocycles as well as methods of using them to treat disorders associated with the HCV protease.
Compounds As Ns3-Serine Protease Inhibitors Of Hepatitis C Virus
View pageUS Patent:
6894072, May 17, 2005
Filed:
Jan 21, 2003
Appl. No.:
10/348094
Inventors:
Ashok Arasappan - Bridgewater NJ, US
Frank Bennett - Cranford NJ, US
Stephane L. Bogen - Somerset NJ, US
Kevin X. Chen - Edison NJ, US
Edwin Jao - Warren NJ, US
Yi-Tsung Liu - Morris Township NJ, US
Raymond G. Lovey - West Caldwell NJ, US
Vincent S. Madison - Mountain Lakes NJ, US
Latha G. Nair - Edison NJ, US
F. George Njoroge - Warren NJ, US
Anil K. Saksena - Upper Montclair NJ, US
Mousumi Sannigrahi - Summit NJ, US
Srikanth Venkatraman - Woodbrige NJ, US
Viyyoor M. Girijavallabhan - Parsippany NJ, US
Frank Bennett - Cranford NJ, US
Stephane L. Bogen - Somerset NJ, US
Kevin X. Chen - Edison NJ, US
Edwin Jao - Warren NJ, US
Yi-Tsung Liu - Morris Township NJ, US
Raymond G. Lovey - West Caldwell NJ, US
Vincent S. Madison - Mountain Lakes NJ, US
Latha G. Nair - Edison NJ, US
F. George Njoroge - Warren NJ, US
Anil K. Saksena - Upper Montclair NJ, US
Mousumi Sannigrahi - Summit NJ, US
Srikanth Venkatraman - Woodbrige NJ, US
Viyyoor M. Girijavallabhan - Parsippany NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K031/403
C07D209/02
C07D403/12
C07D209/02
C07D403/12
US Classification:
514422, 548465, 548469, 548537, 548950, 546192, 544359, 514423
Abstract:
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
Peptides As Ns3-Serine Protease Inhibitors Of Hepatitis C Virus
View pageUS Patent:
7012066, Mar 14, 2006
Filed:
Jul 19, 2001
Appl. No.:
09/908955
Inventors:
Anil K. Saksena - Upper Montclair NJ, US
Viyyoor Moopil Girijavallabhan - Parsippany NJ, US
Raymond G. Lovey - West Caldwell NJ, US
Edwin Jao - Warren NJ, US
Frank Bennett - Piscataway NJ, US
Jinping L. Mc Cormick - Edison NJ, US
Haiyan Wang - Cranbury NJ, US
Russell E. Pike - Stanhope NJ, US
Stephane L. Bogen - Somerset NJ, US
Tin-Yau Chan - Edison NJ, US
Yi-Tsung Liu - Morris Township NJ, US
Zhaoning Zhu - East Windsor NJ, US
F. George Njoroge - Warren NJ, US
Ashok Arasappan - Bridgewater NJ, US
Tejal Parekh - Mountain View CA, US
Ashit K. Ganguly - Upper Montclair NJ, US
Kevin X. Chen - Iselin NJ, US
Srikanth Venkatraman - Fords NJ, US
Henry A. Vaccaro - South Plainfield NJ, US
Patrick A. Pinto - Morris Plains NJ, US
Bama Santhanam - Bridgewater NJ, US
Scott Jeffrey Kemp - San Diego CA, US
Odile Esther Levy - San Diego CA, US
Marguerita Lim-Wilby - La Jolla CA, US
Susan Y. Tamura - Santa Fe NM, US
Wanli Wu - Edison NJ, US
Siska Hendrata - Edison NJ, US
Yuhua Huang - Scotch Plains NJ, US
Viyyoor Moopil Girijavallabhan - Parsippany NJ, US
Raymond G. Lovey - West Caldwell NJ, US
Edwin Jao - Warren NJ, US
Frank Bennett - Piscataway NJ, US
Jinping L. Mc Cormick - Edison NJ, US
Haiyan Wang - Cranbury NJ, US
Russell E. Pike - Stanhope NJ, US
Stephane L. Bogen - Somerset NJ, US
Tin-Yau Chan - Edison NJ, US
Yi-Tsung Liu - Morris Township NJ, US
Zhaoning Zhu - East Windsor NJ, US
F. George Njoroge - Warren NJ, US
Ashok Arasappan - Bridgewater NJ, US
Tejal Parekh - Mountain View CA, US
Ashit K. Ganguly - Upper Montclair NJ, US
Kevin X. Chen - Iselin NJ, US
Srikanth Venkatraman - Fords NJ, US
Henry A. Vaccaro - South Plainfield NJ, US
Patrick A. Pinto - Morris Plains NJ, US
Bama Santhanam - Bridgewater NJ, US
Scott Jeffrey Kemp - San Diego CA, US
Odile Esther Levy - San Diego CA, US
Marguerita Lim-Wilby - La Jolla CA, US
Susan Y. Tamura - Santa Fe NM, US
Wanli Wu - Edison NJ, US
Siska Hendrata - Edison NJ, US
Yuhua Huang - Scotch Plains NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
Dendreon Corporation - Seattle WA
Dendreon Corporation - Seattle WA
International Classification:
A61K 38/07
A61K 38/06
C07K 5/08
C07K 5/10
A61K 38/06
C07K 5/08
C07K 5/10
US Classification:
514 18, 530330, 530331
Abstract:
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
Peptides As Ns3-Serine Protease Inhibitors Of Hepatitis C Virus
View pageUS Patent:
7169760, Jan 30, 2007
Filed:
Jul 19, 2001
Appl. No.:
09/909012
Inventors:
Anil K. Saksena - Upper Montclair NJ, US
Viyyoor Moopil Girijavallabhan - Parsippany NJ, US
Stephane L. Bogen - Somerset NJ, US
Raymond G. Lovey - West Caldwell NJ, US
Edwin Jao - Warren NJ, US
Frank Bennett - Piscataway NJ, US
Jinping L. Mc Cormick - Edison NJ, US
Haiyan Wang - Cranbury NJ, US
Russell E. Pike - Stanhope NJ, US
Yi-Tsung Liu - Morris Township NJ, US
Tin-Yau Chan - Edison NJ, US
Zhaoning Zhu - East Windsor NJ, US
Ashok Arasappan - Bridgewater NJ, US
Kevin X. Chen - Iselin NJ, US
Srinkanth Venkatraman - Fords NJ, US
Tejal Parekh - Mountain View CA, US
Patrick A. Pinto - Morris Plains NJ, US
Bama Santhanam - Bridgewater NJ, US
F. George Njoroge - Warren NJ, US
Ashit K. Ganguly - Upper Montclair NJ, US
Henry A. Vaccaro - South Plainfield NJ, US
Scott Jeffrey Kemp - San Diego CA, US
Odile Esther Levy - San Diego CA, US
Marguerita Lim-Wilby - La Jolla CA, US
Susan Y. Tamura - Santa Fe NM, US
Viyyoor Moopil Girijavallabhan - Parsippany NJ, US
Stephane L. Bogen - Somerset NJ, US
Raymond G. Lovey - West Caldwell NJ, US
Edwin Jao - Warren NJ, US
Frank Bennett - Piscataway NJ, US
Jinping L. Mc Cormick - Edison NJ, US
Haiyan Wang - Cranbury NJ, US
Russell E. Pike - Stanhope NJ, US
Yi-Tsung Liu - Morris Township NJ, US
Tin-Yau Chan - Edison NJ, US
Zhaoning Zhu - East Windsor NJ, US
Ashok Arasappan - Bridgewater NJ, US
Kevin X. Chen - Iselin NJ, US
Srinkanth Venkatraman - Fords NJ, US
Tejal Parekh - Mountain View CA, US
Patrick A. Pinto - Morris Plains NJ, US
Bama Santhanam - Bridgewater NJ, US
F. George Njoroge - Warren NJ, US
Ashit K. Ganguly - Upper Montclair NJ, US
Henry A. Vaccaro - South Plainfield NJ, US
Scott Jeffrey Kemp - San Diego CA, US
Odile Esther Levy - San Diego CA, US
Marguerita Lim-Wilby - La Jolla CA, US
Susan Y. Tamura - Santa Fe NM, US
Assignee:
Schering Corporation - Kenilworth NJ
Dendreon Corporation - Seattle WA
Dendreon Corporation - Seattle WA
International Classification:
A61K 38/05
A61K 31/44
A61K 31/16
A61K 31/227
A61K 31/44
A61K 31/16
A61K 31/227
US Classification:
514 19, 514616, 564154, 564152, 564155
Abstract:
The present invention discloses novel peptide compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
Compounds As Inhibitors Of Hepatitis C Virus Ns3 Serine Protease
View pageUS Patent:
7186747, Mar 6, 2007
Filed:
Feb 24, 2005
Appl. No.:
11/065531
Inventors:
Ashok Arasappan - Bridgewater NJ, US
F. George Njoroge - Warren NJ, US
Angela I. Padilla-Acevedo - Austin TX, US
Kevin X. Chen - Edison NJ, US
Frank Bennett - Cranford NJ, US
Mousumi Sannigrahi - Summit NJ, US
Stephane L. Bogen - Somerset NJ, US
Srikanth Venkatraman - Woodbridge NJ, US
Edwin Jao - Dayton MD, US
Anil K. Saksena - Upper Montclair NJ, US
Viyyoor M. Girijavallabhan - Parsippany NJ, US
F. George Njoroge - Warren NJ, US
Angela I. Padilla-Acevedo - Austin TX, US
Kevin X. Chen - Edison NJ, US
Frank Bennett - Cranford NJ, US
Mousumi Sannigrahi - Summit NJ, US
Stephane L. Bogen - Somerset NJ, US
Srikanth Venkatraman - Woodbridge NJ, US
Edwin Jao - Dayton MD, US
Anil K. Saksena - Upper Montclair NJ, US
Viyyoor M. Girijavallabhan - Parsippany NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31/401
C07D 207/08
C07D 207/08
US Classification:
514423, 548537
Abstract:
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
Peptides As Ns3-Serine Protease Inhibitors Of Hepatitis C Virus
View pageUS Patent:
7244721, Jul 17, 2007
Filed:
Jan 18, 2002
Appl. No.:
10/052386
Inventors:
Anil K. Saksena - Upper Montclair NJ, US
Viyyoor Moopil Girijavallabhan - Parsippany NJ, US
Raymond G. Lovey - West Caldwell NJ, US
Edwin Jao - Warren NJ, US
Frank Bennett - Piscataway NJ, US
Jinping L. Mc Cormick - Edison NJ, US
Haiyan Wang - Cranbury NJ, US
Russell E. Pike - Stanhope NJ, US
Stephane L. Bogen - Somerset NJ, US
Tin-Yau Chan - Edison NJ, US
Yi-Tsung Liu - Morris Township NJ, US
Zhaoning Zhu - East Windsor NJ, US
F. George Njoroge - Warren NJ, US
Ashok Arasappan - Bridgewater NJ, US
Tejal Parekh - Mountain View CA, US
Ashit K. Ganguly - Upper Montclair NJ, US
Kevin X. Chen - Iselin NJ, US
Srikanth Venkatraman - Woodbridge NJ, US
Henry A. Vaccaro - South Plainfield NJ, US
Patrick A. Pinto - Morris Plains NJ, US
Bama Santhanam - Bridgewater NJ, US
Scott Jeffrey Kemp - San Diego CA, US
Odile Esther Levy - San Diego CA, US
Marguerita Lim-Wilby - La Jolla CA, US
Susan Y. Tamura - San Diego CA, US
Wanli Wu - Edison NJ, US
Siska Hendrata - Rockaway NJ, US
Yuhua Huang - Scotch Plains NJ, US
Jesse K. Wong - Monroe Township NJ, US
Latha G. Nair - Scotch Plains NJ, US
Viyyoor Moopil Girijavallabhan - Parsippany NJ, US
Raymond G. Lovey - West Caldwell NJ, US
Edwin Jao - Warren NJ, US
Frank Bennett - Piscataway NJ, US
Jinping L. Mc Cormick - Edison NJ, US
Haiyan Wang - Cranbury NJ, US
Russell E. Pike - Stanhope NJ, US
Stephane L. Bogen - Somerset NJ, US
Tin-Yau Chan - Edison NJ, US
Yi-Tsung Liu - Morris Township NJ, US
Zhaoning Zhu - East Windsor NJ, US
F. George Njoroge - Warren NJ, US
Ashok Arasappan - Bridgewater NJ, US
Tejal Parekh - Mountain View CA, US
Ashit K. Ganguly - Upper Montclair NJ, US
Kevin X. Chen - Iselin NJ, US
Srikanth Venkatraman - Woodbridge NJ, US
Henry A. Vaccaro - South Plainfield NJ, US
Patrick A. Pinto - Morris Plains NJ, US
Bama Santhanam - Bridgewater NJ, US
Scott Jeffrey Kemp - San Diego CA, US
Odile Esther Levy - San Diego CA, US
Marguerita Lim-Wilby - La Jolla CA, US
Susan Y. Tamura - San Diego CA, US
Wanli Wu - Edison NJ, US
Siska Hendrata - Rockaway NJ, US
Yuhua Huang - Scotch Plains NJ, US
Jesse K. Wong - Monroe Township NJ, US
Latha G. Nair - Scotch Plains NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
Dendreon Corporation - Seattle WA
Dendreon Corporation - Seattle WA
International Classification:
A61K 31/497
A61K 31/407
A61K 31/454
A61K 31/4025
A61K 31/407
A61K 31/454
A61K 31/4025
US Classification:
51421021, 530330, 530331
Abstract:
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
Compounds As Inhibitors Of Hepatitis C Virus Ns3 Serine Protease
View pageUS Patent:
7425576, Sep 16, 2008
Filed:
Dec 21, 2006
Appl. No.:
11/644708
Inventors:
Ashok Arasappan - Bridgewater NJ, US
F. George Njoroge - Warren NJ, US
Angela I. Padilla-Acevedo - Garwood NJ, US
Kevin X. Chen - Edison NJ, US
Frank Bennett - Cranford NJ, US
Mousumi Sannigrahi - Summit NJ, US
Stephane L. Bogen - Somerset NJ, US
Srikanth Venkatraman - Woodbridge NJ, US
Edwin E. Jao - Dayton MD, US
Anil K. Saksena - Upper Montclair NJ, US
Viyyoor M. Girijavallabhan - Parsippany NJ, US
F. George Njoroge - Warren NJ, US
Angela I. Padilla-Acevedo - Garwood NJ, US
Kevin X. Chen - Edison NJ, US
Frank Bennett - Cranford NJ, US
Mousumi Sannigrahi - Summit NJ, US
Stephane L. Bogen - Somerset NJ, US
Srikanth Venkatraman - Woodbridge NJ, US
Edwin E. Jao - Dayton MD, US
Anil K. Saksena - Upper Montclair NJ, US
Viyyoor M. Girijavallabhan - Parsippany NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31/401
C07D 207/08
C07D 207/08
US Classification:
514423, 548537
Abstract:
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.